|
SYNRG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02069999999388E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.043150E-04 |
| Normal-vs-Stage2 |
6.390400E-04 |
| Normal-vs-Stage3 |
2.17440000005453E-06 |
| Normal-vs-Stage4 |
4.29170000004753E-06 |
| Stage1-vs-Stage2 |
5.841400E-01 |
| Stage1-vs-Stage3 |
1.929830E-01 |
| Stage1-vs-Stage4 |
9.464500E-02 |
| Stage2-vs-Stage3 |
7.025400E-01 |
| Stage2-vs-Stage4 |
4.673200E-01 |
| Stage3-vs-Stage4 |
6.443800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.47910000000995E-06 |
| Normal-vs-AfricanAmerican |
9.628100E-02 |
| Normal-vs-Asian |
7.350600E-04 |
| Caucasian-vs-AfricanAmerican |
1.992380E-01 |
| Caucasian-vs-Asian |
9.198600E-01 |
| AfricanAmerican-vs-Asian |
2.395600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.16890000193493E-08 |
| Normal-vs-Female |
5.64639999999228E-05 |
| Male-vs-Female |
7.404000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.191700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.01389999999746E-05 |
| Normal-vs-Age(61-80Yrs) |
6.62930000006057E-07 |
| Normal-vs-Age(81-100Yrs) |
1.965890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.214600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.059500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.843600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.913800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.650600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.361000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.295900E-02 |
| Classical-VS-Follicular |
3.860400E-03 |
| Classical-VS-Other |
4.923700E-02 |
| Classical-VS-Normal |
3.406800E-04 |
| Tall-VS-Follicular |
9.312200E-01 |
| Tall-VS-Other |
2.958400E-01 |
| Tall-VS-Normal |
4.50000000000728E-05 |
| Follicular-VS-Other |
3.751600E-01 |
| Follicular-VS-Normal |
1.64570000005249E-06 |
| Other-VS-Normal |
1.582910E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10909999998066E-06 |
| Normal-vs-N1 |
6.20009999999782E-05 |
| N0-vs-N1 |
5.660200E-01 |
|
|
